Technology

  • DNA Encoded Library (DEL) is an innovative drug discovery technology rapidly gaining wide spread interest in the pharmaceutical industry in recent years. It combines the power of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics to create vast number of novel molecules for hit identification and lead generation. HitGen has been building a large collection of novel, diverse and drug-like DELs as its primary drug discovery platform.


  • Read More

Pipeline

  • Currently HitGen has more than 20 internal projects in research, with 1 in Phase I, 2 in PCC generation and 2 in lead generation,mainly focused on oncology, CVD, inflammation/ respiratory, metabolism and ophthalmology.
  • Read More
Target Project Progress Therapeutic Area
Target: Deacetylase Target: Phosphatase Target: Dehydrogenase Target: Dioxygenase Target: Kinase Target: Protease Target: Lipase Target: Methyltransferase Target: GPCR Target:  Protein Protein Interaction Project progress: Target Preparation Project progress: Target Screening Project progress: Hit Validation Project progress: Hit2Lead Optimization Project progress: Lead Optimization Project progress: PCC generation Therapeutic Area: Ophthalmology Therapeutic Area: Metabolism Therapeutic Area: Inflammation/Respiratory Therapeutic Area: Cardiovascular Therapeutic Area: Oncology
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 1
  • 2
  • 3
  • 4
  • 5

Partnering

  • 01

    DNA Encoded Library Screening
    HitGen will screen its most up to date proprietary DELs (hundreds of billions of novel small molecules and macrocycles) against targets provided by the partners.
  • 02

    Custom DNA Encoded Library Synthesis
    HitGen will be responsible for the design and synthsis of DNA encoded library base on partner's specification. 
  • 03

    Innovative Drug Project Collaboration

    HitGen initiates a number of innovative drug discovery projects. These projects can be the subject of collaboration, which cover the areas of oncology, CVD, inflammation/ respiratory, metabolism and ophthalmology.


Read More
  • Careers

  • Here, we build future together! 

    Here, we create innovative medicine for patients!

  • Read More
-->
福建时时彩开奖列表 山西十一选五遗漏走势图带 北京pk10谁控制的 河南快赢481中奖规则 云南11选5技巧 2013年排列三走势图 2018买基金能赚钱吗 零点棋牌官方免费下载 幸运赛车开奖结果奖金 加拿大快乐8开加拿大28 冠通棋牌手机官方版下载 体彩七星彩走势图48期 海南环岛赛车彩票控 股票是什么 山东老11选5开奖结果走势图 彩票站怎样组织双色球合买 江苏十一选五最新开奖